Chantal Pichon is a professor at the University of Orléans (France), holder of the Chair of Innovation Excellence at the Institut Universitaire de France (Paris) and appointed guest professor at La Charité Berlin Institute of Health. She leads interdisciplinary projects at the interface of chemistry and biology.
‍
Over the past decade, she has been particularly interested in mRNA-based vaccines and therapies and is developing innovative formulations for vaccination, cell therapy and protein replacement therapy.
‍
Chantal Pichon has patented mRNA bioproduction technology, a complete paradigm shift from in vitro production and a revolutionary new use of yeast as a cell factory. It plans to build an economically sustainable biotechnology process for the production of high-quality therapeutic mRNAs.